About Mahi Drugs Private Limited
Data last updated: 31 December 2025
Mahi Drugs Private Limited is a private limited company based in Vishakhapatnam, Andhra Pradesh, India, a subsidiary of Sms Lifesciences India Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 17 December 2012, the company has been in operation for over 14 years.
Registered with ROC Vijayawada under CIN U24233AP2012PTC084875.
Capital: an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹7.07 Cr. It is led by directors including Madhu Rao Maganty and Venkata Praveen Talluri.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.82 Jawaharlal Nehru Pharma City Parawada, Vishakhapatnam, Andhra Pradesh, India – 531019.
As per the financials filed for FY 2023, the company reported a revenue of ₹35.67 Cr, a growth of 9.49% compared to the previous year.
The company has a workforce of approximately 201 employees as per the latest available data. It operates as a subsidiary of Sms Lifesciences India Limited.
As per MCA filings, the company has open charges of ₹26.76 Cr and satisfied charges of ₹7.07 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smslife.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressPlot No.82 Jawaharlal Nehru Pharma City Parawada, Vishakhapatnam, Andhra Pradesh, India – 531019
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Mahi Drugs Private Limited
Mahi Drugs Private Limited operates primarily in the manufacturing sector. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for Mahi Drugs Private Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Mahi Drugs Private Limited
Mahi Drugs Private Limited is audited by Rambabu & Co for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Rambabu & Co | Locked | Locked | Locked |
Complete auditor history for Mahi Drugs Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mahi Drugs Private Limited
Mahi Drugs Private Limited is currently managed by 4 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu Rao Maganty | Nominee Director | 28 May 2022 | 4 Years 2 Months | Current |
|
Venkata Praveen Talluri
Also directs:
Haleos Labs Limited
|
Managing Director | 25 Jul 2020 | 6 Years 1 Months | Current |
|
Veeravenkata Satyanarayana Murthy Talluri
Also directs:
Haleos Labs Limited
|
Director | 07 Apr 2018 | 8 Years 4 Months | Current |
| Sarath Kumar Pakalapati | Director | 09 Aug 2022 | 4 Years 0 Months | Current |
Financials of Mahi Drugs Private Limited FY 2025 filings available
Mahi Drugs Private Limited reported revenue of ₹35.67 Cr (up 9.49% YoY) for FY 2023.
Ten-year financial statements for Mahi Drugs Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Mahi Drugs Private Limited
Shareholding and ownership data for Mahi Drugs Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mahi Drugs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2019 | Others | ₹7.5 Cr | Open |
| 21 Jun 2019 | Others | ₹19.26 Cr | Open |
| 17 Aug 2020 | Others | ₹1.92 Cr | Satisfied |
| 30 Jan 2016 | Hdfc Bank Limited | ₹2.95 Cr | Satisfied |
| 06 Jan 2016 | Hdfc Bank Limited | ₹2.2 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Mahi Drugs Private Limited
Mahi Drugs Private Limited has a workforce of 201 employees as of Mar 30, 2024.
Employee and EPFO history for Mahi Drugs Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Mahi Drugs Private Limited
GST registrations and filing compliance for Mahi Drugs Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Mahi Drugs Private Limited
Credit ratings, litigation, and regulatory alerts for Mahi Drugs Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mahi Drugs Private Limited
MSME payment history for Mahi Drugs Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mahi Drugs Private Limited
Corporate group structure for Mahi Drugs Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mahi Drugs Private Limited
MCA filings and documents for Mahi Drugs Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Mahi Drugs Private Limited
Frequently Asked Questions about Mahi Drugs Private Limited
Mahi Drugs Private Limited is an active private limited company in the pharma sector based in Vishakhapatnam, Andhra Pradesh, India. It was incorporated on 17 December 2012 (14+ years old) and is registered under CIN U24233AP2012PTC084875. The company has 201 employees.
Mahi Drugs Private Limited reported revenue of ₹35.67 Cr for FY 2023 (up 9.49% YoY).
The current directors of Mahi Drugs Private Limited are:
- Madhu Rao Maganty - Nominee Director
- Venkata Praveen Talluri - Managing Director
- Veeravenkata Satyanarayana Murthy Talluri - Director
- Sarath Kumar Pakalapati - Director
The primary industry of Mahi Drugs Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Mahi Drugs Private Limited can be reached at the registered office: Plot No.82 Jawaharlal Nehru Pharma City Parawada, Vishakhapatnam, Andhra Pradesh, India – 531019, or through the website smslife.in.
The authorised capital is ₹7.5 Cr, and the paid-up capital is ₹7.07 Cr.